These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30118663)

  • 21. Cannabinoids, cannabinoid receptors and tinnitus.
    Smith PF; Zheng Y
    Hear Res; 2016 Feb; 332():210-216. PubMed ID: 26433054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetics and the endocannabinoid system signaling: An intricate interplay modulating neurodevelopment.
    Gomes TM; Dias da Silva D; Carmo H; Carvalho F; Silva JP
    Pharmacol Res; 2020 Dec; 162():105237. PubMed ID: 33053442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.
    Kozela E; Juknat A; Vogel Z
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
    Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
    Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Endocannabinoid System as a Therapeutic Target in Glaucoma.
    Cairns EA; Baldridge WH; Kelly ME
    Neural Plast; 2016; 2016():9364091. PubMed ID: 26881140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving role of the endocannabinoid system in gynaecological cancer.
    Ayakannu T; Taylor AH; Willets JM; Konje JC
    Hum Reprod Update; 2015; 21(4):517-35. PubMed ID: 25958409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocannabinoid system in normal and pathological brain ageing.
    Bilkei-Gorzo A
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3326-41. PubMed ID: 23108550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
    Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
    Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the endocannabinoid system: future therapeutic strategies.
    Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
    Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids and atherosclerosis.
    Fisar Z
    Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumour actions of cannabinoids.
    Hinz B; Ramer R
    Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endocannabinoid system in neuropathological states.
    Orgado JM; Fernández-Ruiz J; Romero J
    Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling.
    García-Ovejero D; Arévalo-Martín Á; Navarro-Galve B; Pinteaux E; Molina-Holgado E; Molina-Holgado F
    Biochem Soc Trans; 2013 Dec; 41(6):1577-82. PubMed ID: 24256257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids in arthritis: current views and perspective.
    Barrie N; Kuruppu V; Manolios E; Ali M; Moghaddam M; Manolios N
    Int J Rheum Dis; 2017 Jul; 20(7):789-797. PubMed ID: 28736968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids as Potential Molecules for Addiction Disorders.
    Martín Giménez VM; Mazzei L; Sanz R; Manucha W
    Curr Protein Pept Sci; 2022; 23(3):152-157. PubMed ID: 35538819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.